Srinagar Observer
Friday, May 23, 2025
  • Home
  • Top News
  • Kashmir
  • Jammu
  • Business
  • Sports
  • National
  • World
  • Editorial

    The Habitual Shifts

    Assuring Crime Free Society

    Stimulating Young Energy

    An Ethical Denial

    Beating Inflation

    The Timely Exigence

    Extension in Academics

     Aiding Healthcare

    Development in Disguise

    Gender-Free Conviction

  • Edit-Oped
  • ePaper
No Result
View All Result
Srinagar Observer
  • Home
  • Top News
  • Kashmir
  • Jammu
  • Business
  • Sports
  • National
  • World
  • Editorial

    The Habitual Shifts

    Assuring Crime Free Society

    Stimulating Young Energy

    An Ethical Denial

    Beating Inflation

    The Timely Exigence

    Extension in Academics

     Aiding Healthcare

    Development in Disguise

    Gender-Free Conviction

  • Edit-Oped
  • ePaper
No Result
View All Result
Srinagar Observer
No Result
View All Result
Home Latest

DRDO issues directions on usage of anti-COVID drug 2-DG

SO NEWS Desk by SO NEWS Desk
June 1, 2021
in Latest, Top News
A A
0
Share on FacebookShare on TwitterWhatsApp

New Delhi, Jun 1 (PTI) The DRDO on Tuesday issued directions on the usage of its 2-DG drug on COVID-19 patients, stating that caution should be exercised while prescribing this medicine to people who have comorbidites such as uncontrolled diabetes, severe cardiac problem and acute respiratory distress syndrome.
The Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients in early May.

The first batch of this oral drug, developed by the Defence Research and Development Organisation (DRDO), was released on May 17 by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.

RELATED POSTS

Information Department  condoles demise  of former Section Officer-Mohammad Sultan Bhat

Prof. Nilofer Khan re-appointed as Vice Chancellor University of Kashmir

On Tuesday, the DRDO on Twitter issued “directions for usage of this drug for COVID-19 patients as per DCGI approval”.

“Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe COVID-19 patients for maximum duration up to 10 days,” it mentioned.

Uncontrolled diabetes, severe cardiac problem, acute respiratory distress syndrome, severe hepatic and renal impairment patients have not been studied yet with 2DG, hence caution should be exercised, it noted.

“2DG should not be given to pregnant and lactating women and patients below 18 years,” it stated.

Patients or their attendants are advised to request their hospital to contact Dr Reddy’s Laboratories (DRL) for medicine supply.

The anti-COVID-19 therapeutic application of 2-DG drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of DRDO, in collaboration with DRL.

The DRDO said the drug is approved for emergency use as adjunct therapy to the standard treatment of COVID-19 patients in the hospital settings.

The defence ministry on May 8 said that the clinical trials of 2-DG showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

The approval of the drug has come at a time India has been grappling with a record-breaking wave of coronavirus pandemic that has stretched the country’s healthcare infrastructure to its limit.

The drug comes in powder form in sachet and is taken orally by dissolving it in water.

In efficacy trends, the defence ministry said, patients treated with 2-DG showed faster symptomatic cure than the standard of care on various endpoints.

Related

ShareTweetSend
SO NEWS Desk

SO NEWS Desk

Related Posts

Information Department  condoles demise  of former Section Officer-Mohammad Sultan Bhat

by SO NEWS Desk
May 23, 2025
0

Srinagar, May 23: The Officers and Officials of the Joint Directorate of Information, Kashmir, have expressed their sorrow over the...

Prof. Nilofer Khan re-appointed as Vice Chancellor University of Kashmir

by SO NEWS Desk
May 16, 2025
0

SRINAGAR, MAY 16 - The Chancellor of the J&K Universities, Lieutenant Governor Manoj Sinha, on Friday re-appointed Prof. Nilofer Khan...

Karnah Admin Launches Comprehensive Bunker Survey After Intense Border Shelling

by SO NEWS Desk
May 16, 2025
0

Karnah Kupwara: On the direction of Deputy Commissioner Kupwara, Ayushi Sudan, the Karnah administration carried out extensive inspections in Tangdar...

DC Kupwara Ayushi Sudan Visits LOC in Tangdhar

by SO NEWS Desk
May 11, 2025
0

KUPWARA, KARNAH, MAY 11 - DC Kupwara Ayushi Sudan today visited the Line of Control (LOC) in Tangdhar, reaching the...

JKAS members grieved over tragic demise of ADC Rajouri

by SO NEWS Desk
May 10, 2025
0

SRINAGAR, MAY 10 - Members of Jammu and Kashmir Administrative Service (JKAS) on Saturday expressed grief and sorrow over the...

Next Post

Amid pandemic, SKIMS Bemina offering a helping hand to drug abuse victims

Bangladesh Cabinet minister's mobile phone snatched by mugger in Dhaka's street

Digital Edition

Srinagar Observer

Srinagar Observer is an English Newspaper based in Jammu and Kashmir

CATEGORY

  • Business
  • Edit-Oped
  • Editorial
  • Jammu
  • Kashmir
  • Latest
  • National
  • Photo Gallery
  • Sports
  • Top News
  • Uncategorized
  • World

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 9,375 other subscribers

Archives

No Result
View All Result
  • Home
  • About Us
  • Contact Us
  • Advertise

© 2024 Srinagar Observer - Designed by GITS.

No Result
View All Result
  • Home
  • Top News
  • Kashmir
  • Jammu
  • Business
  • Sports
  • National
  • World
  • Editorial
  • Edit-Oped
  • ePaper

© 2024 Srinagar Observer - Designed by GITS.